Editorial: Clostridium difficile infection in the elderly: Update in epidemiology and treatment;Editorial: Clostridium difficile en el anciano: Actualización epidemiológica y terapéutica

Medicina Clinica

Volumn 133, Issue 5, 2009, Pages 180-183

  Pareja Sierra, Teresa ^a  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; CEPHALOSPORIN; CLAVULANIC ACID; CLINDAMYCIN; COLESTYRAMINE; METRONIDAZOLE; QUINOLONE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EDITORIAL; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GERIATRICS; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; MORTALITY; TREATMENT DURATION; AGED; PSEUDOMEMBRANOUS COLITIS;

AGED; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 68249155318     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.11.020     Document Type: Article

References (53)

1. M.E. Taylor, and B.A. Oppenheim Hospital-acquired infection in elderly patients J Hosp Infect 38 1998 245 260
2. A. Selva, M. Yuste, L. Armadans, B. Almirante, A. San José, and M. Vilardell Factores de riesgo de infección por Clostridium difficile en pacientes ancianos. Estudio de casos y controles Med Clín (Barc) 115 2000 499 500
3. C. Bertiú, and J. Romero Clostridium difficile Med Clin (Barc) 108 1997 146 155
4. M. Liang Clostridium difficile infection Rev Clin Gerontol 13 2003 1 9
5. L. Mc Farland Update on the changing epidemiolgy of CDAD Gastroenterol Hepatol 5 2008 40 48
6. L. Mc Farmland, P. Mulligan, and R. Kwok Nosocomial acquisition of Clostridium difficile infection N Eng J Med 320 1989 204 210
7. J. Pépin, L. Valiquette, and B. Cossette Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec CMAJ 173 2005 1037 1042
8. J. Pépin, L. Valiquette, M.E. Alary, P. Villemure, A. Pelletier, and K. Forget Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity CMAJ 171 2004 466 472
9. L. Valiquette, D.E. Low, J. Pépin, and A. McGeer Clostridium difficile infection in hospitals: A brewing storm CMAJ 6 2004 17127 17129
10. Estudio de prevalencia de enfermedades nosocomiales en España. EPINE 1996-2006:17 años. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene; Madrid, 2007.
11. C. Mc Donald, G. Killgore, A. Thompson, R. Owens, D. Pharm, and S. Kazakova An epidemic toxigenic gene variant of Clostridium difficile N Eng J Med 353 2005 2433 2441
12. J. Barlett, and T. Perl The new Clostridium difficile-what does it mean? N Eng J Med 353 2005 2503 2504
13. E.J. Kuijper, B. Coignard, J.S. Brazier, C. Suetens, D. Drudy, and C. Wiuff Update of Clostridium difficile - associated disease due to PCR ribotype 027 in Europe Euro Surveill 12 2007 1
14. D. Drudy Emergence and control of fluoroquinolone-resistant toxine-A negative, toxine-B positive Clostridium difficile Emerg Infect Dis 28 2007 932 940
15. R. Gaynes Outbreak of Clostridium difficile infection in long-term care facility: association with gatifloxacin use Clin Infect Dis 38 2004 640 645 (Pubitemid 38333858)
16. L. Kyne, S. Sougioultzis, L.V. McFarland, and C.P. Kelly Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea Infect Control Hosp Epidemiol 23 2002 653 659
17. L.V. McFarland Diarrhoea associated with antibiotic use BMJ 14 2007 33554 33555
18. L.V. McFarland, J.E. Clarridge, H.W. Beneda, and G.J. Raugi Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a veterans administration health care system Clin Infect Dis 45 2007 1141 1151
19. T. Pareja, and M. Hornillos Factores epidemiológicos, clínicos y analíticos asociados a diarrea por Clostridium difficile en la población anciana hospitalizada. Estudio de casos y controles Rev Esp Geriatr Gerontol 42 2007 257 262
20. J.M. Starr, H. Martin, J. Mc Coopery, G. Gibson, and I. Paxton Risk factors for Clostridium difficile colonization and toxin production Age Ageing 32 2003 657 660
21. S. Johnson Antibody responses to clostridial infection in humans Clin Infect Dis. Supl 2 1997 s173 s177
22. E. Bouza, T. Peláez, and P. Catalan Enfermedad asociada a Clostridium difficile Medicine (Ed esp.) 7 1998 3422 3426
23. B. Geric, S. Johnson, D.N. Gerding, M. Grabnar, and M. Rupnik Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins J Clin Microbiol 41 2003 5227 5232
24. S. Johnson, S.A. Kent, K.J. O'Leary, M.M. Merrigan, S.P. Sambol, and L.R. Peterson Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin An immunoassay Ann Intern Med 135 2001 434 438
25. L. Kyne, M. Warny, A. Qamar, and C.P. Kelly Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A N Engl J Med 342 2000 390 397
26. L. Kyne, M. Warny, A. Qamar, and C.P. Kelly Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea Lancet 357 2001 189 193
27. P. Gianasca, and M. Warny Active and passive immunization against Clostridium difficile diarrhea and colitis Vaccine 22 2004 848 856
28. N. González, J. Gómez Pavón, and J.L. Martínez Porras Diagnóstico y control de la infección causada por Clostridium difficile Rev Esp Geriatr Gerontol 40 2005 310 319
29. S. Poutanen, and A.E. Simor Clostridium difficile associated diarrhea in adults Can Med Association J 6 2004 171 51
30. G. Dobson, C. Hickey, and J. Trinder Clostridium difficile colitis causing toxic megacolon, severe sepsis and enterocolitis Intens Care Med 29 2003 1030
31. A. Jacobs, K. Barnard, R. Fishel, and G. Gradon Extra colonic manifestations of Clostridium difficile infections Medicine 80 2001 88 101
32. M.H. Athkinson, and B.D. Mc Leod Reactive arthritis associated with Clostridium difficile enteritis J Reumatol 15 1998 520 522
33. D.N. Gerding Disease associated with Clostridium difficile infection Ann Int Med 110 1989 255 257
34. R. Feteky Guidelines for the diagnosis and management of Clostridium difficile associated diarrhea and colitis Am J Gastroenterol 92 1997 739 750
35. M. Delmé Laboratory diagnosis of Clostridium difficile disease Clin Microbiol Infect 7 2001 411 416
36. C. Guibault, A.C. Labbé, L. Poirier, L. Busque, C. Béliveau, and M. Lavadiere Development and evaluation of PCR method for detection of the Clostridium difficile toxin B gene in stool specimens J Clin Microbiol 4 2002 288 290
37. T. Peláez, L. Alcalá, R. Alonso, M. Rodríguez- Créixems, J.M. García-Lechuz, and E. Bouza Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin J Antimicrob Agents Chemother 46 6 2002 1647 1650
38. R. Fekety, J. Silva, C. Kauffman, and H.G. Deery Treatment of antibiotic associated Clostridium difficile colitis with oral vancomicin: Comparison of two dosage regimens Am J Med 86 1989 15 19
39. E.P. Shen, and C.M. Surawicz The changing face of Clostridium difficile: What treatment options remain? Am J Gastroenterol 102 2007 2789 2792
40. J.B. Morris, R.M. Zollinger, and T.A. Stellato Role of surgery in antibiotic induced pseudo membranous colitis Am J Surg 160 1990 535 539
41. J. Salcedo, S. Keates, C. Pothoulakis, M. Warny, I. Castiglioulo, and J.T. LaMont Intravenous inmunoglobulin therapy for severe Clostridium difficile colitis Gut 41 1997 366 370
42. T. Peláez, L. Alcalá, R. Alonso, A. Martín- López, V. García-Arias, and M. Marín In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole Antimicrob Agents Chemother 49 2005 1157 1159
43. P.L. Hinkson, C. Dinardo, D. DeCiero, J.D. Klinger, and R.H. Barker Jr. Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile J. Antimicrob Agents Chemother 52 2008 2190 2195
44. T. Louise, J. Peppe, K. Watt, D. Jonhson, R. Mohamed, and G. Row Tolevamer, a novel non antibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile associated diarrhea Clin Infect Dis. 2006 43411 43420
45. I. Thompson Clostridium difficile-associated disease: Update and focus on non-antibiotic strategies Age Ageing 37 2008 14 18
46. L.V. McFarland Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostridium difficile disease Am J Gastroenterol 101 2006 812 822
47. L.V. Mc Farland Alternative treatments for Clostridium difficile disease. What really works? J Med Microbiol 54 2005 101 111
48. J. Pépin, L. Valiquette, S. Gagnon, S. Routhier, and I. Brazeau Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027 Am J Gastroenterol 102 2007 2781 2788
49. F.J. Tedesco, D. Gordon, and W.C. Forston Approach to patients with multiple relapses of antibiotic associated colitis Am J Gastroenterol 80 1985 867 868
50. G. Young, and M. Mc Donald Antibiotic associated colitis: Why do patients relapse? Gastroenterology 90 1986 1098 1099
51. C. Kelly, and T. LaMont Clostridium difficile-More difficult than ever N Engl J Med. 359 2008 18
52. S. Barret Clostridium difficile: The next step in mandatory reporting J Hosp Infect 56 2004 83 84
53. Guideline: Clostridium difficile infection: how to deal with the problem. English Department of Health and Health Protection Agency. Londres, Reino Unido. 2009.